nitazoxanide has been researched along with Antibody Deficiency Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adebayo, A; Hautala, T; Icenogle, J; Perelygina, L; Seppänen, M; Sullivan, KE | 1 |
| Bode, MK; Glumoff, V; Hägg, PM; Hautala, NM; Hautala, TJ; Murk, JL; Perelygina, L; Renko, MH; Rusanen, HT; Schneider-Hohendorf, T; Schwab, N; Seppänen, MRJ; Sullivan, KE; Vuorinen, T | 1 |
| Buchbinder, D; Deripapa, E; Dorsey, MJ; Eloit, M; Hauck, F; Hautala, T; Icenogle, J; Moshous, D; Perelygina, L; Sullivan, KE; Uriarte, I | 1 |
3 other study(ies) available for nitazoxanide and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency.
Topics: A549 Cells; Animals; Antigens, Viral; Antiviral Agents; Cell Survival; Chlorocebus aethiops; Female; Granuloma; Human Umbilical Vein Endothelial Cells; Humans; Immunologic Deficiency Syndromes; Inhibitory Concentration 50; Nitro Compounds; Protein Transport; Rubella; Rubella virus; Skin; Thiazoles; Treatment Outcome; Vero Cells; Virus Replication | 2017 |
Nitazoxanide May Modify the Course of Progressive Multifocal Leukoencephalopathy.
Topics: Adolescent; Adult; Antiparasitic Agents; Antiviral Agents; Brain; Epilepsy; Female; Humans; Immunologic Deficiency Syndromes; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Nitro Compounds; Polyomavirus; Polyomavirus Infections; Skin; Thiazoles | 2018 |
Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus-Associated Granuloma.
Topics: Adolescent; Child; Child, Preschool; Female; Granuloma; Humans; Immunologic Deficiency Syndromes; Infant; Male; Nitro Compounds; Retrospective Studies; Rubella; Rubella virus; T-Lymphocytes; Thiazoles; Vaccination | 2019 |